Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.
bmj;369/jun15_13/m2385/FAF1faPhoto credit: Judith ReaThe north London GP Nicolas “Nic” Rea spent a year agonising over whether to take […]
A GP who has been suspended from the UK medical register for the past 18 months for accepting […]
The new NHS covid-19 contact tracing service for England identified and advised 26 985 contacts to self isolate […]
The increased levels of violence reported during this pandemic are alarming.1 Not only because of the lasting consequences […]
The indication is approved under accelerated approval
The formulation and an expanded indication for Tivicay tablets are currently under review in Europe
The drug giant has agreed to supply 400 million doses of the vaccine under the deal
TRV027 targets cell pathways thought to be major drivers of severe illness in COVID-19
Rozlytrek is one of a new group of histology-independent cancer treatments designed to treat tumours regardless of where […]